Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6556 AL 6570

Concurrent Amyotrophic Lateral Sclerosis and Huntington's Disease

Takahashi R, Furuta M, Nagashima K, Ikeda Y.

Intern Med. 2025 Jan 15;64(2):297-300. doi: 10.2169/internalmedicine.3232-23. Epub 2024 Jun 20.

Exploring the link between dopamine dysregulation and eating disorders: A narrative review

Tharwani ZH, Shaeen SK, Zahid K, Ahmed S, Naqrashi R, Murtaza A, Mughal S, Hasanain M, Anjum MU, Eljack MMF, Zaidi SW.

J Neuroendocrinol. 2025 Oct;37(10):e70070. doi: 10.1111/jne.70070. Epub 2025 Jul 23.

Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases

Cui CX, Shao XN, Li YY, Qiao L, Lin JT, Guan LH.

World J Stem Cells. 2025 Aug 26;17(8):107717. doi: 10.4252/wjsc.v17.i8.107717.

The Huntington's disease drug pipeline: a review of small molecules and their therapeutic targets

Khan S, Bano N, Uversky VN, Ahamad S, Bhat SA.

Prog Mol Biol Transl Sci. 2025;211:169-207. doi: 10.1016/bs.pmbts.2024.08.006. Epub 2024 Oct 16.

Balancing Microglial Density and Activation in Central Nervous System Development and Disease

Wang S, Pan L, Sun C, Ma C, Pan H.

Curr Issues Mol Biol. 2025 May 9;47(5):344. doi: 10.3390/cimb47050344.

Valbenazine Sprinkle: An Alternative Formulation of Valbenazine for Oral Administration in Patients With Dysphagia

Giri N, Jimenez R, Rees L, Mar A, Bristow A, Hebert M, Maynard-Scott J, Zhang H, Brar S.

Clin Transl Sci. 2025 Nov;18(11):e70390. doi: 10.1111/cts.70390.

The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets

Ekwudo MN, Gubert C, Hannan AJ.

FEBS J. 2025 Mar;292(6):1282-1315. doi: 10.1111/febs.17102. Epub 2024 Mar 1.

Systematic Review with Meta-Analysis of Biofluid Markers for Huntington's Disease

Paulsen JS, Bovin NA, Clemsen JD, Weiss A, Key AM, Janz ML, Pinto A, Burks DK, Zetterberg H, Shannon KM.

Mov Disord. 2025 Dec;40(12):2578-2595. doi: 10.1002/mds.70067. Epub 2025 Oct 13.

Dysregulation of melatonin rhythm in Parkinson's and Huntington's disease: a systematic review and meta-analysis

Suram RP, Fatima R, Madhuvilakku R, Jung JH, Kim SJ, Hong Y.

Front Aging Neurosci. 2025 Oct 9;17:1637881. doi: 10.3389/fnagi.2025.1637881. eCollection 2025.

Frequency of depression in Huntington's disease: A systematic review and meta-analysis

Zadegan SA, Ramirez F, Park JW, Rocha NP, Furr Stimming E, Teixeira AL.

J Huntingtons Dis. 2025 Feb;14(1):43-58. doi: 10.1177/18796397241301774. Epub 2024 Dec 5.

Semaglutide and the pathogenesis of progressive neurodegenerative disease: the central role of mitochondria

Stefano GB, Büttiker P, Weissenberger S, Raboch J, Anders M.

Front Neuroendocrinol. 2025 Oct;79:101217. doi: 10.1016/j.yfrne.2025.101217. Epub 2025 Oct 3.

Effective housing and support models for people with Huntington's disease: A scoping review

Cubis L, Davis E, McDonald S, Loy CT, Gosden-Kaye E, Jarman H, Winkler D, Douglas J.

J Huntingtons Dis. 2025 Nov;14(4):340-353. doi: 10.1177/18796397251378091. Epub 2025 Oct 17.

Research trends of piezoelectric materials in neurodegenerative disease applications

Wang X, Sun Y, Han C, Meng X, Wen K, Wu J, Min P, Li K, Zhang Y.

Bioact Mater. 2025 Jun 13;52:366-392. doi: 10.1016/j.bioactmat.2025.06.022. eCollection 2025 Oct.

Decoding Glycosylation in Neurodegenerative Diseases: Mechanistic Insights and Therapeutic Opportunities

Yu H, Chen X, Yang Y, Gu M, Ren K, Wei Z.

FASEB J. 2025 Oct 31;39(20):e71160. doi: 10.1096/fj.202502809R.

Imaging brain inflammation and blood brain barrier permeability in neurological and psychiatric diseases: a review

Kovbasyuk Z, Tefera E, Li C, Baete SH, Steriade C.

J Neuroinflammation. 2025 Nov 19;22(1):275. doi: 10.1186/s12974-025-03598-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias